Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like Creutzfeldt-Jakob disease

4Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Here, we present a patient with Creutzfeldt-Jakob disease (CJD) who developed initial symptoms mimicking progressive supranuclear palsy (PSP). Before the development of typical CJD symptoms, functional imaging supported a diagnosis of PSP when [123I]-FP-CIT-SPECT showed a defect in striatal dopamine transporter binding, while [18F]-fluorodeoxyglucose PET showed cortical hypometabolism suggestive of Lewy body dementia. However, the postmortem neuropathological examination was indicative of CJD only, without tau protein or Lewy body findings. This case demonstrates that CJD should be taken into account in rapidly progressing atypical cases of parkinsonism, even when functional imaging supports a diagnosis of a movement disorder. © 2014 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Rissanen, E., Kaasinen, V., Sonninen, P., Röyttä, M., & Päivärinta, M. (2014). Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like Creutzfeldt-Jakob disease. Case Reports in Neurology, 6(1), 28–33. https://doi.org/10.1159/000358483

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free